Arcosa

ACA · NYSE · Industrials · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$2.3B$2.3B$2.6B$2.6B$2.9B$2.9B7.2% margin7.2% marginRevenueNet margin

Quarterly · last 8

Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26$598.6M$598.6M$664.7M$664.7M$640.4M$640.4M$547.6M$547.6M$647.5M$647.5M$797.8M$797.8M$571.7M$571.7M$658.7M$658.7M49.9% margin49.9% marginRevenueNet margin

Revenue (FY2025)

$2.9B

Net margin

7.2%

ROE

7.9%

Revenue CAGR (2y)

+11.8%

Profit CAGR (2y)

+14.4%

EPS (FY2025)

4.24

Net profit (FY2025)

$208.4M

Ask MarketChacha about ACA

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$2.9B$208.4M4.247.2%7.9%
FY2024$2.6B$93.7M1.913.6%3.9%
FY2023$2.3B$159.2M3.266.9%6.8%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q2$658.7M$328.5M6.6749.9%
2026Q1$571.7M$37.8M0.776.6%
2025Q3$797.8M$73.0M1.489.2%
2025Q2$647.5M$59.7M1.229.2%
2025Q1$547.6M$23.6M0.484.3%
2024Q3$640.4M$16.6M0.342.6%
2024Q2$664.7M$45.6M0.936.9%
2024Q1$598.6M$39.2M0.806.5%
2023Q3$591.7M$35.5M0.726.0%
2023Q2$584.8M$40.9M0.847.0%
2023Q1$549.2M$55.7M1.1410.1%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2025

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.